https://www.cgtlive.com/view/phase-trial-uniqure-huntington-disease-gene-therapy-amt-130-hits-primary-end-point
Phase 1/2 Trial for uniQure's Huntington Disease Gene Therapy AMT-130 Hits Primary End Point |...
Oct 8, 2026 - The study also met a key secondary end point.
primary end pointhuntington diseasegene therapyphasetrial
https://www.targetedonc.com/view/eftisarc-neo-trial-meets-primary-end-point-in-soft-tissue-sarcoma
EFTISARC-NEO Trial Meets Primary End Point in Soft Tissue Sarcoma | Targeted Oncology -...
Oct 16, 2026 - The EFTISARC-NEO trial of eftilagimod alfa with radiotherapy and pembrolizumab in resectable soft tissue sarcoma achieved its primary end point.
primary end pointsoft tissue sarcomaneotrialmeets
https://www.contagionlive.com/view/sulopenem-narrowly-misses-primary-end-point-in-phase-3-ciai-study
Sulopenem Narrowly Misses Primary End Point in Phase 3 cIAI Study | Contagion Live
Oct 15, 2026 - The difference in outcomes was 4.7% with a 95% confidence interval on that difference of -10.3% to 1.0%. This fell short of non-inferiority which required that...
primary end pointsulopenemnarrowlymissesphase